The impact of a secondary, rare, non-pathogenic PKD1 variant on disease progression in autosomal dominant polycystic kidney disease.

Elhassan EAE, Collins KE, Heneghan S, Gilbert E, Yang H, Senum SR, Schauer RS, Elbarougy DE, Madden SF, Murray SL, Sadeghi-Alavijeh O, Carmichael J, Gale D, Osman SM, Kennedy C, Griffin MD, Casserly L, Moloney B, O'Hara P, Mallawaarachchi A, Ciurli F, Genomics England Consortium, Graziano C, Wolff CA, Schönauer R, LaManna G, Durand A, Limou S, Halbritter J, Capelli I, McCann E, Harris PC, Cavalleri GL, Benson KA, Conlon PJ

Open source

DOI
10.1007/s40620-025-02211-x
Published
2025 Jun
Container
Journal of nephrology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40620-025-02211-x,
  title = {The impact of a secondary, rare, non-pathogenic PKD1 variant on disease progression in autosomal dominant polycystic kidney disease.},
  author = {Elhassan EAE and Collins KE and Heneghan S and Gilbert E and Yang H and Senum SR and Schauer RS and Elbarougy DE and Madden SF and Murray SL and Sadeghi-Alavijeh O and Carmichael J and Gale D and Osman SM and Kennedy C and Griffin MD and Casserly L and Moloney B and O'Hara P and Mallawaarachchi A and Ciurli F and Genomics England Consortium and Graziano C and Wolff CA and Schönauer R and LaManna G and Durand A and Limou S and Halbritter J and Capelli I and McCann E and Harris PC and Cavalleri GL and Benson KA and Conlon PJ},
  year = {2025},
  journal = {Journal of nephrology},
  doi = {10.1007/s40620-025-02211-x},
  url = {https://doi.org/10.1007/s40620-025-02211-x}
}

RIS

TY  - JOUR
TI  - The impact of a secondary, rare, non-pathogenic PKD1 variant on disease progression in autosomal dominant polycystic kidney disease.
AU  - Elhassan EAE
AU  - Collins KE
AU  - Heneghan S
AU  - Gilbert E
AU  - Yang H
AU  - Senum SR
AU  - Schauer RS
AU  - Elbarougy DE
AU  - Madden SF
AU  - Murray SL
AU  - Sadeghi-Alavijeh O
AU  - Carmichael J
AU  - Gale D
AU  - Osman SM
AU  - Kennedy C
AU  - Griffin MD
AU  - Casserly L
AU  - Moloney B
AU  - O'Hara P
AU  - Mallawaarachchi A
AU  - Ciurli F
AU  - Genomics England Consortium
AU  - Graziano C
AU  - Wolff CA
AU  - Schönauer R
AU  - LaManna G
AU  - Durand A
AU  - Limou S
AU  - Halbritter J
AU  - Capelli I
AU  - McCann E
AU  - Harris PC
AU  - Cavalleri GL
AU  - Benson KA
AU  - Conlon PJ
PY  - 2025
JO  - Journal of nephrology
DO  - 10.1007/s40620-025-02211-x
UR  - https://doi.org/10.1007/s40620-025-02211-x
ER  - 

APA

EAE, E., KE, C., S, H., E, G., H, Y., SR, S., RS, S., DE, E., SF, M., SL, M., O, S., J, C., D, G., SM, O., C, K., MD, G., L, C., B, M., P, O., A, M., F, C., Consortium, G. E., C, G., CA, W., R, S., G, L., A, D., S, L., J, H., I, C., E, M., PC, H., GL, C., KA, B., & PJ, C. (2025). The impact of a secondary, rare, non-pathogenic PKD1 variant on disease progression in autosomal dominant polycystic kidney disease.. Journal of nephrology. https://doi.org/10.1007/s40620-025-02211-x

Source records